Suchergebnisse - "Lin, Xiaoyan"

PubPharm (543)

1

SUBSTITUTED 1,4-DIHYDRO-1,6-NAPHTHYRIDINE AMIDE AND USE THEREOF

enthalten in: Europäisches Patentamt | 2024

von LI YUNFEI | YU JIAN | ZHANG ZHEN | +3

2

A novel approach to evaluation of tumor response for advanced pulmonary adenocarcinoma using the intertumoral heterogeneity response score

enthalten in: MedComm | 2024

von Zheng, X. | Lu, T. | Wu, S. | +26

3

Correction : A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer

enthalten in: BMC cancer | 2024

von Huang, W. | Wang, C. | Shen, Y. | +12

ErratumFor: BMC Cancer. 2024 Jan 5;24(1):39. - PMID 38182995

4

Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer

enthalten in: BMC cancer | 2024

von Huang, W. | Wang, C. | Shen, Y. | +12

5

Cannabinoid CB₂receptors in primary sensory neurons are implicated in CB₂agonist-mediated suppression of paclitaxel-induced neuropathic nociception and sexually-dimorphic sparing of morphine tolerance

enthalten in: bioRxiv.org | 2024

von Guenther, K. | Lin, X. | Xu, Z. | +5

6

Cannabinoid CB 2 receptors in primary sensory neurons are implicated in CB 2 agonist-mediated suppression of paclitaxel-induced neuropathic nociception and sexually-dimorphic sparing of morphine tolerance

enthalten in: bioRxiv : the preprint server for biology | 2024

von Guenther, K. | Lin, X. | Xu, Z. | +5

7

The FBXW7-binding sites on FAM83D are potential targets for cancer therapy

enthalten in: Breast cancer research : BCR | 2024

von Jiang, X. | Wang, Y. | Guo, L. | +7

8

The FBXW7-binding sites on FAM83D are potential targets for cancer therapy

enthalten in: Breast cancer research | 2024

von Jiang, X. | Wang, Y. | Guo, L. | +7

9

LPA1 SMALL MOLECULE ANTAGONIST

enthalten in: Europäisches Patentamt | 2024

von LI YUNFEI | TAN LIANG | MO MINGGUANG | +4

10

LPA1 SMALL MOLECULE ANTAGONIST

enthalten in: Europäisches Patentamt | 2024

von LI YUNFEI | TAN LIANG | MO MINGGUANG | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[55]